FDA OKs First Drug for Primary Membranous Nephropathy | HappeningNow.news

Health · 9 views

FDA OKs First Drug for Primary Membranous Nephropathy

Source Summary Published 6h 42m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 9 Community interest
Brief read Under 1 min brief 26 words

Summary

(MedPage Today) -- The FDA has once again expanded the label for the B-cell depleter obinutuzumab (Gazyva), this time to include treatment of primary membranous nephropathy.

Read original at MedPage Today

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page